These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 7783361)

  • 1. [Plasma fatty acids, lipids, lipoprotein and macroangiopathy].
    Ninomiya K; Maruhama Y
    Rinsho Byori; 1995 May; 43(5):449-53. PubMed ID: 7783361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic dyslipidemia and atherosclerosis.
    Shepherd J
    Schweiz Med Wochenschr; 1994 Nov; 124(44):1933-7. PubMed ID: 7973520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease.
    Koga H; Sugiyama S; Kugiyama K; Fukushima H; Watanabe K; Sakamoto T; Yoshimura M; Jinnouchi H; Ogawa H
    Eur Heart J; 2006 Apr; 27(7):817-23. PubMed ID: 16434416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of decreased serum adiponectin for type IIb hyperlipidaemia and increased cholesterol levels of very-low-density lipoprotein in type II diabetic patients.
    Yoshida H; Hirowatari Y; Kurosawa H; Tada N
    Clin Sci (Lond); 2005 Sep; 109(3):297-302. PubMed ID: 15907189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.
    Koga H; Sugiyama S; Kugiyama K; Watanabe K; Fukushima H; Tanaka T; Sakamoto T; Yoshimura M; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2005 May; 45(10):1622-30. PubMed ID: 15893178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS; Kashyap ML
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fatty acid composition of phosphatidylcholine and levels of lipids and lipoproteins in hyperlipoproteinemia. I. Relation to HDL lipoprotein].
    Zák A; Zeman M; Tvrzická E
    Cas Lek Cesk; 1998 Jun; 137(12):368-71. PubMed ID: 9721473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.
    Kobayashi J; Nakajima K; Nohara A; Kawashiri M; Yagi K; Inazu A; Koizumi J; Yamagishi M; Mabuchi H
    Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic dyslipidaemia.
    Erkelens DW
    Eur Heart J; 1998 Jul; 19 Suppl H():H27-40. PubMed ID: 9717062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High risk levels of lipoprotein(a) in Pakistani patients with type 2 diabetes mellitus.
    Habib SS; Aslam M
    Saudi Med J; 2003 Jun; 24(6):647-51. PubMed ID: 12847596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma fatty acids and lipoproteins in type 2 diabetic patients.
    Lapolla A; Sartore G; Della Rovere GR; Romanato G; Zambon S; Marin R; Manzato E; Fedele D
    Diabetes Metab Res Rev; 2006; 22(3):226-31. PubMed ID: 16308886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Remnant lipoprotein cholesterol level measured by homogeneous assay reflects the quantity of intermediate-density lipoprotein].
    Murano T; Kiuchi M; Moteki M; Miyashita Y; Watanabe H; Hiruta N; Shirai K
    Rinsho Byori; 2008 May; 56(5):367-72. PubMed ID: 18546884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantitative characterization of the main lipid and apoprotein components of plasma lipoproteins in men with types I and II diabetes mellitus with and without coronary heart disease].
    Madanat AIa; Slavina LS; Perova NV; Metel'skaia VA; Zholus NP
    Ter Arkh; 1987; 59(11):18-22. PubMed ID: 3441860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dyslipidemias and coronary disease].
    Douste-Blazy P; Douste-Blazy L
    Ann Biol Clin (Paris); 1986; 44(5):559-64. PubMed ID: 3544979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipoprotein Z].
    Kajiyama G; Otsuki T; Kawanishi M
    Nihon Rinsho; 1994 Dec; 52(12):3084-9. PubMed ID: 7853693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of Apolipoprotein A1, B100 and Lipoprotein (a) in Controlled and Uncontrolled Diabetic Patients and in Non-Diabetic Healthy People.
    Patel VI; Patel KP; Makadia MG; Shah AD; Chaudhari KS; Nilayangode HN
    J Clin Diagn Res; 2017 Feb; 11(2):BC01-BC05. PubMed ID: 28384849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.